Browse > Article
http://dx.doi.org/10.11620/IJOB.2013.38.3.093

The Role of HS-1200 Induced Autophagy in Oral Cancer Cells  

Jang, Nam-Mi (Department of Oral Anatomy, School of Dentistry, Pusan National University)
Oh, Sang-Hun (Department of Oral Anatomy, School of Dentistry, Pusan National University)
Kim, In-Ryoung (Department of Oral Anatomy, School of Dentistry, Pusan National University)
Park, Hae-Ryoun (Department of Oral Pathology, School of Dentistry, Pusan National University)
Park, Bong-Soo (Department of Oral Anatomy, School of Dentistry, Pusan National University)
Publication Information
International Journal of Oral Biology / v.38, no.3, 2013 , pp. 93-100 More about this Journal
Abstract
Bile acids and synthetic bile acid derivatives induce apoptosis in various kinds of cancer cells and thus have anticancer properties. Recently, it has been suggested that autophagy may play an important role in cancer therapy. However, few data are available regarding the role of autophagy in oral cancers and there have been no reports of autophagic cell death in OSCCs (oral squamous cell carcinoma cells) induced by HS-1200, a synthetic bile acid derivative. We thus examine whether HS-1200 modulates autophagy in OSCCs. Our findings indicate that HS-1200 has anticancer effects in OSCCs, and we observed in these cells that autophagic vacuoles were visible by monodansylcadaverine (MDC)and acridine orange staining. When we analyzed HS-1200-treated OSCC cells for the presence of biochemical markers, we observed that this treatment directly affects the conversion of LC-3II, degradation of p62/SQSTM1 and full-length beclin-1, cleavage of ATG5-12 and the activation of caspase. An autophagy inhibitor suppressed HS-1200-induced cell death in OSCCs, confirming that autophagy acts as a pro-death signal in these cells. Furthermore, HS-1200 shows anticancer activity against OSCCs via both autophagy and apoptosis. Our current findings suggest that HS-1200 may potentially contribute to oral cancer treatment and thus provide useful information for the future development of a new therapeutic agent.
Keywords
HS-1200; autophagy; apoptosis; OSCC;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Park YH, JA Kim, JH Baek, EJ Jung, TH Kim, H Suh, MH Park, and KW Kim, Induction of apoptosis in HepG2 human hepatocellular carcinoma cells by a novel derivative of ursodeoxycholic acid (UDCA). Arch Pharm Res, 1997;20:29-33.   DOI
2 Im E and JD Martinez, Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells. J Nutr, 2004;134:483-6.   DOI
3 Moon B, MC Kim, and JS Park, Synthetic CDCA derivatives-induced apoptosis of stomach cancer cell line SNU-1 cells. Cancer Res Treat, 2004;36:132-9.   DOI
4 Gozuacik D and A Kimchi, Autophagy as a cell death and tumor suppressor mechanism. Oncogene, 2004;23:2891-906.   DOI
5 Clayman GL, S Ebihara, M Terada, K Mukai, and H Goepfert, Report of the Tenth International Symposium of the Foundation for Promotion of Cancer Research: Basic and Clinical Research in Head and Neck cancer. Jpn J Clin Oncol, 1997;27:361-8.   DOI
6 Shen J, C Huang, L Jiang, F Gao, Z Wang, Y Zhang, J Bai, H Zhou, and Q Chen, Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines. Biochem Pharmacol, 2007;73:1901-9.   DOI
7 Lo WL, SY Kao, LY Chi, YK Wong, and RC Chang, Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg, 2003;61:751-8.   DOI
8 Shintani S, C Li, M Mihara, SK Klosek, N Terakado, S Hino, and H Hamakawa, Anti-tumor effect of radiation response by combined treatment with angiogenesis inhibitor, TNP-470, in oral squamous cell carcinoma. Oral Oncol, 2006;42:66-72.   DOI
9 Bell RB, D Kademani, L Homer, EJ Dierks, and BE Potter, Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity? J Oral Maxillofac Surg, 2007;65:229-36.   DOI
10 Katona BW, S Anant, DF Covey, and WF Stenson, Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines. J Biol Chem, 2009;284:3354-64.   DOI
11 Park SE, HJ Choi, SB Yee, HY Chung, H Suh, YH Choi, YH Yoo, and ND Kim, Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells. Int J Oncol, 2004;25:231-6.
12 Powell AA, JM LaRue, AK Batta, and JD Martinez, Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HCT116 cells. Biochem J, 2001;356:481-6.   DOI
13 Fimia GM, A Stoykova, A Romagnoli, L Giunta, S Di Bartolomeo, R Nardacci, M Corazzari, C Fuoco, A Ucar, P Schwartz, P Gruss, M Piacentini, K Chowdhury, and F Cecconi, Ambra1 regulates autophagy and development of the nervous system. Nature, 2007;447:1121-5.
14 Ichimura Y, E Kominami, K Tanaka, and M Komatsu, Selective turnover of p62/A170/SQSTM1 by autophagy. Autophagy, 2008;4:1063-6.   DOI
15 Pankiv S, TH Clausen, T Lamark, A Brech, JA Bruun, H Outzen, A Overvatn, G Bjorkoy, and T Johansen, p62/ SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem, 2007;282:24131-45.   DOI
16 Jounai N, F Takeshita, K Kobiyama, A Sawano, A Miyawaki, KQ Xin, KJ Ishii, T Kawai, S Akira, K Suzuki, and K Okuda, The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci U S A, 2007;104:14050-5.   DOI
17 Kihara A, Y Kabeya, Y Ohsumi, and T Yoshimori, Beclinphosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep, 2001;2:330-5.   DOI
18 Sun Q, W Fan, and Q Zhong, Regulation of Beclin 1 in autophagy. Autophagy, 2009;5:713-6.   DOI
19 Djavaheri-Mergny M, MC Maiuri, and G Kroemer, Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene, 2010;29:1717-9.   DOI
20 Wirawan E, L Vande Walle, K Kersse, S Cornelis, S Claerhout, I Vanoverberghe, R Roelandt, R De Rycke, J Vers purten, W Declercq, P Agostinis, T Vanden Berghe, S Lippens, and P Vandenabeele, Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis, 2010;1:e18.   DOI
21 Cho DH, YK Jo, JJ Hwang, YM Lee, SA Roh, and JC Kim, Caspase-mediated cleavage of ATG6/Beclin-1 links apoptosis to autophagy in HeLa cells. Cancer Lett, 2009;274:95-100.   DOI
22 Betin VM and JD Lane, Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers mitochondrial targeting and apoptosis. J Cell Sci, 2009;122:2554-66.   DOI
23 Seo SY, EJ Jun, SM Jung, KH Kim, YJ Lim, BS Park, JK Kim, S Lee, H Suh, ND Kim, and YH Yoo, Synthetic chenodeoxycholic acid derivative HS-1200-induced apoptosis of p815 mastocytoma cells is augmented by co-treatment with lactacystin. Anticancer Drugs, 2003;14:219-25.   DOI
24 Park SE, SW Lee, MA Hossain, MY Kim, MN Kim, EY Ahn, YC Park, H Suh, GY Kim, YH Choi, and ND Kim, A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells. Cancer Lett, 2008;270:77-86.   DOI
25 Liu H, CK Qin, GQ Han, HW Xu, WH Ren, and CY Qin, Synthetic chenodeoxycholic acid derivative, HS-1200, induces apoptosis of human hepatoma cells via a mitochondrial pathway. Cancer Lett, 2008;270:242-9.   DOI
26 Yee SB, YS Song, SH Jeong, HS Lee, SY Seo, JH Kim, H Suh, ND Kim, and YH Yoo, A novel chenodeoxycholic derivative HS-1200 enhances radiation-induced apoptosis in MCF-7 cells. Oncol Rep, 2007;17:919-23.
27 Yorimitsu T and DJ Klionsky, Autophagy: molecular machinery for self-eating. Cell Death Differ, 2005;12 Suppl2:1542-52.   DOI
28 Codogno P, [Autophagy in cell survival and death]. J Soc Biol, 2005;199:233-41.   DOI
29 Michaud M, I Martins, AQ Sukkurwala, S Adjemian, Y Ma, P Pellegatti, S Shen, O Kepp, M Scoazec, G Mignot, S Rello-Varona, M Tailler, L Menger, E Vacchelli, L Galluzzi, F Ghiringhelli, F di Virgilio, L Zitvogel, and G Kroemer, Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science, 2011;334:1573-7.   DOI
30 Zhang J, Y Li, X Chen, T Liu, Y Chen, W He, Q Zhang, and S Liu, Autophagy is involved in anticancer effects of matrine on SGC-7901 human gastric cancer cells. Oncol Rep, 2011;26:115-24.
31 Guo XL, D Li, F Hu, JR Song, SS Zhang, WJ Deng, K Sun, QD Zhao, XQ Xie, YJ Song, MC Wu, and LX Wei, Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Lett, 2012.
32 Giannopoulou E, A Antonacopoulou, P Matsouka, and HP Kalofonos, Autophagy: novel action of panitumumab in colon cancer. Anticancer Res, 2009;29:5077-82.
33 Tsujimoto Y and S Shimizu, Another way to die: autophagic programmed cell death. Cell Death Differ, 2005;12Suppl 2:1528-34.   DOI
34 Martinez JD, ED Stratagoules, JM LaRue, AA Powell, PR Gause, MT Craven, CM Payne, MB Powell, EW Gerner, and DL Earnest, Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr Cancer, 1998;31:111-8.   DOI
35 Qiao D, W Chen, ED Stratagoules, and JD Martinez, Bile acid-induced activation of activator protein-1 requires both extracellular signal-regulated kinase and protein kinase C signaling. J Biol Chem, 2000;275:15090-8.   DOI
36 Lum JJ, DE Bauer, M Kong, MH Harris, C Li, T Lindsten, and CB Thompson, Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell, 2005;120:237-48.   DOI
37 Roesly HB, MR Khan, HD Chen, KA Hill, N Narendran, GS Watts, X Chen, and K Dvorak, The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: The role of deoxycholic acid. Am J Physiol Gastrointest Liver Physiol, 2012.
38 Zhang G, MA Park, C Mitchell, T Walker, H Hamed, E Studer, M Graf, M Rahmani, S Gupta, PB Hylemon, PB Fisher, S Grant, and P Dent, Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling. J Biol Chem, 2008;283:24343-58.   DOI
39 Payne CM, C Crowley-Skillicorn, H Holubec, K Dvorak, C Bernstein, MP Moyer, H Garewal, and H Bernstein, Deoxycholate, an endogenous cytotoxin/genotoxin, induces the autophagic stress-survival pathway: implications for colon carcinogenesis. J Toxicol, 2009;2009:785907.
40 Chen LH, CC Loong, TL Su, YJ Lee, PM Chu, ML Tsai, PH Tsai, PH Tu, CW Chi, HC Lee, and SH Chiou, Autophagy inhibition enhances apoptosis triggered by BO-1051, an N-mustard derivative, and involves the ATM signaling pathway. Biochem Pharmacol, 2011;81:594-605.   DOI
41 Ichimura Y and M Komatsu, Selective degradation of p62 by autophagy. Semin Immunopathol, 2010;32:431-6.   DOI
42 Alexander A, SL Cai, J Kim, A Nanez, M Sahin, KH Mac- Lean, K Inoki, KL Guan, J Shen, MD Person, D Kusewitt, GB Mills, MB Kastan, and CL Walker, ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A, 2010;107:4153-8.   DOI
43 Miki H, N Uehara, A Kimura, T Sasaki, T Yuri, K Yoshizawa, and A Tsubura, Resveratrol induces apoptosis via ROStriggered autophagy in human colon cancer cells. Int J Oncol, 2012;40:1020-8.   DOI